CEO Lu Fengyu of SPO Global Inc. (OTC: SPOM) attended the Signing ceremony of strategic framework cooperation that was held in the conference hall of the Jinan High-tech Park on July 8, 2020. This cooperation project is to build "Qilu SPM International Stroke (Jinan) Hospital". This Hospital will be jointly established by Canada SOTA Biomed Investments Inc., SD Superior Medical Group & Jinan Zhongke Xilai Equipment Co., Ltd. Jinan High-tech Park Bonded Area CEO Liu Yechao, and directors from related government’s departments, Mr. Lu Fengyou, Chairman of Canada SOTA Biomed Investments Inc., Chairman of SD Superior Medical Group under Gerpang Healthcare Group, General Manager of Jinan Zhongke Xilai Equipment Co., Ltd., a subsidiary of the Chinese Academy of Sciences Ms. Jiang Tao and about 20 people attended the signing ceremony. The hospital project will be renovated from the existing building in bonded area with a construction area of 20,000 square meters and nearly 300 in-patient beds. It is expected to pilot run operation in June 2021. This hospital will be the first international specialist hospital in Shandong Province that integrates treatment and rehabilitation by the world's top stroke experts. The hospital introduces the most advanced interventional therapy technology in North America, in accordance with international rehabilitation nursing standards and operation management system, to create the world's top stroke specialist hospital. After the hospital is completed, it will receive 5,000 patients and rehabilitation treatment every year.
About SPO Global SPO Global Inc. (OTC Markets: SPOM) recently completed its merger with Gerpang Healthcare Group. (www.gerpanghealthcare.com). Its subsidiary, Shandong Gerpang Biotechnology Co., Ltd. is an innovative and technological private enterprise located in the pharmaceutical Valley Industrial Park of Jinan high tech Zone. Its main business scope includes biomedical R&D, medical information software development and sales, medical high-tech introduction, medical high-quality consumables production and sales, health care products, drugs, medical equipment consumables agency and sales. Company Disclaimers: As a "penny stock" Company, within the meaning of federal and state securities law, SPO Global, Inc. may not avail itself of the Safe Harbor provisions as identified in the Private Securities Litigation Reform Act of 1995. However, SPO Global, Inc. provides the following disclaimer and warning to protect our shareholders, prospective investors and the public at large by alerting them to the risks and uncertainties involved with any investment, and the need to perform their own due diligence and assessment.
Forward-Looking Statements: This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company's business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company's periodic filings with the Securities and Exchange Commission.
Company Contact: fengyoulu@gmail.com
Source: SPO Global Inc.